揭示炎症细胞和皮肤皮肤黑色素瘤之间的联系:洞察表达模式和免疫治疗反应预测的洞察力
Yu Sheng1, Jing Liu1, Miao Zhang2
1Department of Dermatology, The First Affiliated Hospital of Harbin Medical University, Heilongjiang 150001, China.
Mathematical biosciences and engineering : MBE
|December 5, 2023
概括
炎症性特征与皮肤皮肤黑色素瘤 (SKCM) 的更好的结果有关,并预测免疫治疗的反应. 这表明炎症体信号传递是改善SKCM治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 皮肤皮肤黑色素瘤 (SKCM) 是一种高度恶性皮肤癌,预后不佳,往往抗常规疗法.
- 炎症在癌症的发展和进展中起着关键作用,但SKCM炎症酶激活机制尚不清楚.
研究的目的:
- 调查SKCM中炎症相关基因组的作用和预后意义.
- 探索炎症体特征,免疫亚型和对癌症治疗的反应之间的关联.
主要方法:
- 使用SKCM患者的转录基因数据量化表达了六个炎酶相关基因组.
- 进行功能丰富分析和无监督聚类,以识别免疫群和炎症亚型.
- 评估了针对免疫治疗反应的特定炎症组基因 (CASP1,GSDMD,NLRP3,IL1B,IL18) 的预测价值.
主要成果:
- 炎症体特征与临床特征相关,在SKCM患者中显示出有利的预后值.
- 功能性丰富性分析表明,SKCM中的炎症性特征具有致癌作用.
- 确定了免疫群4和SKCM亚型2之间的重叠;特定的炎症组基因预测了对免疫检查点阻塞疗法的反应.
结论:
- 炎症酶信号与SKCM病理和治疗反应有显著的关联.
- 炎症性特征作为一个有利的预后因素和潜在的治疗目标,以改善SKCM患者的治疗结果.
- 了解炎症体通路可以指导皮肤皮肤黑色素瘤的新型治疗策略的开发.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529


